- Product NameDapagliflozin
- Brief DescriptionInhibitors
- Purification99.94%
- Biological ActivityDapagliflozin(BMS512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) is in development for the treatment of type 2 diabetes mellitus (T2DM).
- Target NameSGLT inhibitor
- CAS No. 461432-26-8
- Calculated MW 408.87
- Formulation C21H25ClO6
- Storage 3 years -20˚C powder;2 years -80˚C in solvent;